U.S. market Closed. Opens in 1 day 9 hours 12 minutes

COCH | Envoy Medical, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
Revenue316.00K237.00K310.00KN/A
Cost of Revenue789.00K957.00K769.00KN/A
Gross Profit-473.00K-720.00K-459.00KN/A
Operating Expenses17.90M7.99M6.41M701.00
Selling, General & Admin8.94M3.47M2.47M701.00
Research & Development8.96M4.52M3.94MN/A
Other Operating ExpensesN/A-7.22M-1.80MN/A
Operating Income-18.37M-8.71M-6.87M-700.00
Other Expenses / Income-11.54M-7.22M-1.80M-1.00
Before Tax Income-29.91M-15.92M-8.68M-701.00
Income Tax ExpensesN/A-153.49K-165.56K-206.30K
Net Income-29.91M-15.92M-8.68M-701.00
Interest ExpensesN/AN/AN/AN/A
Basic Shares Outstanding12.55M10.15M10.15M60.38M
Diluted Shares Outstanding12.55M10.15M10.15M60.38M
EBITDA-18.24M-8.63M-6.80M-700.00
EBITDA Margin-5,771.52%-3,641.77%-2,193.55%0.00%
EBIT-29.91M-16.08M-8.84M-207.00K
EBIT Margin-9,464.56%-6,783.33%-2,851.79%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙